Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Mar 11, we reiterated our Neutral recommendation on M&T Bank Corporation (MTB - Analyst Report) based on its healthy mortgage banking revenues, rising net interest income and healthy capital position. However, deteriorating credit metrics, rising expenses and unsettling macro economic issues remain the major causes of concern. M&T Bank retains a Zacks Rank #3 (Hold).
Why Neutral?
M&T Bank’s fourth quarter 2012 earnings came in at $2.23 per share, beating the Zacks Consensus Estimate by 6 cents. Total revenues came in at $1.2 billion, unchanged from the prior quarter. Moreover, revenues surpassed the Zacks Consensus Estimate of $1.1 billion. Further, M&T Bank has delivered an average earnings surprise of 6.75% last year.
Over the last 60 days, the Zacks Consensus Estimate for 2013 hiked by 1%, on the back of upward movement of a number of estimates. Further, an improving net interest income, even during the financial crisis and opportunistic acquisitions, helped the company sustain the Neutral recommendation. Further, healthy capital position and a timely exit from the TARP are the positives for the stock. Extensive capital deployment activities also continue to reinforce investors’ confidence in the stock.
However, the low interest rate environment and changing regulatory landscape are expected to be the headwinds in the future. Further, we remain concerned about the bank’s significant amount of commercial and industrial loans in areas that has experienced less economic growth. In addition, we remain wary of the continuously rising regulatory expenses, which will lead to higher cost of compliance and may temper profitability in the near-to-mid term. In addition, we believe that the company’s flexibility with respect to its investments and lending volumes would be limited in the medium term, given the stricter capital norms.
Other Stocks to Consider
Other banking stocks that are currently performing well include First Defiance Financial Corp. (FDEF - Snapshot Report), Flagstar Bancorp Inc. (FBC - Snapshot Report) and Meta Financial Group, Inc. (CASH - Snapshot Report). All these carry a Zacks Rank #1 (Strong Buy).
Get the full Analyst Report on MTB - FREE
Get the full Snapshot Report on FBC - FREE
Get the full Snapshot Report on CASH - FREE
Get the full Snapshot Report on FDEF - FREE